[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MXPA04005497A - Composiciones nanoparticuladas de isotretinoin. - Google Patents

Composiciones nanoparticuladas de isotretinoin.

Info

Publication number
MXPA04005497A
MXPA04005497A MXPA04005497A MXPA04005497A MXPA04005497A MX PA04005497 A MXPA04005497 A MX PA04005497A MX PA04005497 A MXPA04005497 A MX PA04005497A MX PA04005497 A MXPA04005497 A MX PA04005497A MX PA04005497 A MXPA04005497 A MX PA04005497A
Authority
MX
Mexico
Prior art keywords
isotretinoin
nanoparticulate compositions
nanoparticulate
compositions
preparation
Prior art date
Application number
MXPA04005497A
Other languages
English (en)
Inventor
Malik Rajiv
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MXPA04005497A publication Critical patent/MXPA04005497A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se relaciona a la preparacion de una composicion de isotretinoin nanoparticulada que tiene biodisponibilidad incrementada.
MXPA04005497A 2001-12-06 2001-12-06 Composiciones nanoparticuladas de isotretinoin. MXPA04005497A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2001/002329 WO2003047497A1 (en) 2001-12-06 2001-12-06 Isotretinoin nanoparticulate compositions

Publications (1)

Publication Number Publication Date
MXPA04005497A true MXPA04005497A (es) 2004-10-11

Family

ID=11004222

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005497A MXPA04005497A (es) 2001-12-06 2001-12-06 Composiciones nanoparticuladas de isotretinoin.

Country Status (7)

Country Link
US (1) US20050129773A1 (es)
EP (1) EP1455730A4 (es)
AU (1) AU2001298077A1 (es)
BR (1) BR0117191A (es)
EA (1) EA200400782A1 (es)
MX (1) MXPA04005497A (es)
WO (1) WO2003047497A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000042B (zh) * 2003-07-17 2014-06-04 旗帜药物胶囊公司 控释制剂
CA2606861C (en) * 2005-05-05 2012-08-07 Sanofi-Aventis U.S. Llc Stable nanoparticle formulations
US20070014847A1 (en) * 2005-07-05 2007-01-18 Ahmed Salah U Coated capsules and methods of making and using the same
WO2010109259A1 (es) * 2009-03-26 2010-09-30 Grufarcol Ltda Métoda para preparar formulaciones de gel blando de isotretinoína líquida y la formulaciones obtenidas
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
EP2432453A2 (en) * 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Topical retinoid solutions
MA40312A (fr) * 2014-05-29 2017-04-05 Sun Pharmaceutical Ind Ltd Composition pharmaceutique orale d'isotrétinoïne
WO2015186039A1 (en) * 2014-06-02 2015-12-10 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
AU2015294993A1 (en) 2014-07-31 2017-02-16 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
US9750711B2 (en) 2014-10-01 2017-09-05 Sun Pharmaceutical Industries Limited Low dose oral pharmaceutical composition of isotretinoin
MA40781A (fr) * 2014-10-01 2017-08-08 Sun Pharmaceutical Ind Ltd Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
JP2018520114A (ja) * 2015-05-25 2018-07-26 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． イソトレチノインの１日１回経口医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5429824A (en) * 1992-12-15 1995-07-04 Eastman Kodak Company Use of tyloxapole as a nanoparticle stabilizer and dispersant
KR100274842B1 (ko) * 1998-10-01 2001-03-02 김효근 미립구를 이용한 레티노익산의 서방형 약물방출 시스템
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
CA2281837A1 (en) * 1999-09-07 2001-03-07 Bernard Charles Sherman Solid pharmaceutical composition comprising a retinoid and polyethylene glycol
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients

Also Published As

Publication number Publication date
WO2003047497A1 (en) 2003-06-12
US20050129773A1 (en) 2005-06-16
AU2001298077A1 (en) 2003-06-17
BR0117191A (pt) 2005-05-10
EP1455730A1 (en) 2004-09-15
EP1455730A4 (en) 2006-01-18
EA200400782A1 (ru) 2005-08-25

Similar Documents

Publication Publication Date Title
PT1352046E (pt) Composi??es de branqueadores ?pticos, sua produ??o e sua utiliza??o
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
MXPA03006774A (es) Composiciones de recubrimiento para modificacion de superficies.
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DE60232172D1 (de) Nanocomposit-widerstands zusammensetzungen
PL211243B6 (pl) Kompozycja farmaceutyczna antagonisty receptora tachykininy
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
MXPA04005497A (es) Composiciones nanoparticuladas de isotretinoin.
AP2002002616A0 (en) Antidibetic agents
AU2002343661A1 (en) Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer
AU2002347377A1 (en) Sustained-release compositions
UY27250A1 (es) Fenil-heterociclil-cteres
YU101402A (sh) Visoko prečišćeni preparati simvastatina
GB0104371D0 (en) Color improving stabilizing compositions comprising leucine
EG23126A (en) Novel fungicial compositions
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
TW200640860A (en) Lercanidipine free base
GB0114532D0 (en) Novel compositions
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
DE60212130D1 (en) Carvedilolpolymorph
MXPA05003881A (es) Preparacion de compuestos triazospiro.
EP1291409A3 (en) An oxime as perfuming ingredient
GB0105131D0 (en) Compositions having improved bioavailability

Legal Events

Date Code Title Description
FA Abandonment or withdrawal